Bone regeneration is based on the hypothesis that healthy progenitor cells, either recruited or delivered to an injured site, can ultimately regenerate lost or damaged tissue. Three-dimensional porous polymer scaffolds may enhance bone regeneration by creating and maintaining a space that facilitates progenitor cell migration, proliferation, and differentiation. As an initial step to test this possibility, osteogenic cells were cultured on scaffolds fabricated from biodegradable polymers, and bone development on these scaffolds was evaluated. Porous polymer scaffolds were fabricated from biodegradable polymers of lactide and glycolide. MC3T3-E1 cells were statically seeded onto the polymer scaffolds and cultured in vitro in the presence of ascorbic acid and b -glycerol phosphate. The cells proliferated during the first 4 weeks in culture and formed a space-filling tissue. Collagen messenger RNA levels remained high in these cells throughout the time in culture, which is consistent with an observed increase in collagen deposition on the polymer scaffold. Mineralization of the deposited collagen was initially observed at 4 weeks and subsequently increased. The onset of mineralization corresponded to increased mRNA levels for two osteoblast-specific genes: osteocalcin and bone sialoprotein. Culture of cell/polymer constructs for 12 weeks led to formation of a three-dimensional tissue with architecture similar to that of native bone. These studies demonstrate that osteoblasts within a three-dimensional engineered tissue follow the classic differentiation pathway described for two-dimensional culture. Polymer scaffolds such as these may ultimately be used clinically to enhance bone regeneration by delivering or recruiting progenitor cells to the wound site.
INTRODUCTION B
ONE DEFECTS, which result from tumors, diseases and infections, trauma, biochemical disorders, and abnormal skeletal development, pose a significant health problem. For example, removal of bone tumors can create a critical size defect, which needs to be regenerated to provide skeletal continuity and mechanical support. 1 Periodontal disease, which severely affects approximately 10% of the adult population, 2 is characterized by a loss of attachment between the tooth and underlying bone and bone resorption, and can ultimately lead to tooth loss. Current therapies (e.g., autografts, allografts, and metal prostheses) for bone regeneration or replacement are limited 1 and have inspired a search for improved methods for repairing skeletal defects.
Guided bone regeneration (GBR), or alternatively guided tissue regeneration (GTR) represent a new direction toward bone regeneration. 3, 4 This strategy is based on the premise that progenitor cells capable of tissue regeneration reside in the surrounding tissue. The goal of this strategy is to provide an appropriate environment to induce cell migration from the surrounding tissue into the wound/diseased site. Subsequently, the progenitor cells proliferate, differentiate, and ultimately regenerate the tissue. To provide this environment, a barrier is often used that is intended to allow selective repopulation of the wound site by progenitor cells. This strategy has proven successful clinically; however, current approaches frequently result in inconsistent or incomplete regeneration resulting from the inability to create and maintain the appropriate environment in vivo for tissue regeneration. 5 Tissue engineering, in contrast, attempts to create tissue replacements by culturing cells on synthetic three-dimensional polymer scaffolds. 6 These scaffolds must satisfy several requirements to provide a suitable environment for tissue development. 7 They must create and maintain a space in vivo and ultimately control the size and shape of the regenerated tissue. Highly porous scaffolds, with pore diameters greater than a cell diameter, provide space within the scaffold for tissue development while allowing cells from the surrounding tissue to migrate into the scaffold. 8 The surface of the polymer must provide sites for cell attachment because many cells are anchorage dependent and require a support for survival. As the cells begin to regenerate the tissue, it is desirable to have the scaffold biodegrade to leave behind a completely natural tissue. Recently, a novel gas foaming/particulate leach approach has been developed that allows fabrication of porous (.95%) scaffolds with the desired properties from synthetic copolymers of lactide and glycolide (PLG). 9 PLG has been used extensively in the biomaterials field and is generally considered to be biocompatible. Additionally, the degradation rate of the scaffold can be controlled through the appropriate choice of the lactide-to-glycolide ratio in the polymer. 10 Culture of MC3T3-E1 cells, an osteogenic cell line, on these porous PLG scaffolds was performed to determine if the scaffolds provide an environment that supports the formation of mineralized tissues. In addition, the scaffolds provide a model system to examine the development of a three-dimensional mineralized tissue from bone progenitor cells in vitro. This study specifically analyzed whether bone formation on the polymer scaffolds follows the accepted model of osteoblast differentiation outlined for two-dimensional systems. 11, 12 Ultimately, these scaffolds may find use clinically as cell transplantation vehicles or for guiding bone regeneration.
MATERIALS AND METHODS

Scaffold fabrication
Porous matrices of PLG were fabricated using a previously described gas foaming/particulate leaching process. 9 Briefly, an 85:15 copolymer of D,L-lactide and glycolide (PLG) (Boehringer, Ingelheim Henley, Montvale, NJ) was milled, and the resulting particles were sieved to a particle size ranging between 106 and 250 mm. PLG particles were subsequently mixed with NaCl (Fisher, Pittsburgh, PA) and compression molded. The resulting disc was placed in a pressure vessel and exposed to CO 2 at 800 psi for 48 h. Release of the pressure causes the polymer particles to expand and fuse leading to an interconnected polymer network. Immersion of the disc in water for 24 h leaches the NaCl and creates a porous scaffold. This process creates matrices that are 95% porous with pore diameters ranging from 250 to 400 mm. 9 Cell culture MC3T3-E1 cells were a generous gift from Dr. M. Kumegawa (Josai Dental University, Sakado, Japan). Stock cultures were grown in AA-free a-modified Eagle's medium (MEM-a) and 10% fetal calf serum (FCS; HyClone Labs Logan, UT) containing 100 units/mL of penicillin and streptomycin (Gibco BRL, Gaithersburg, MD) and passaged every 3-4 days. Cells between passages 6 and 8 were statically seeded onto the porous polymer matrices as previously described. 13 Cell-polymer constructs were cultured in a spinner flask (Bellco Glass, Inc., Vineland, NJ) at 25 rpm in a-MEM containing 10% FBS and supplemented with 50 mg/mL ascorbic acid (Aldrich, Milwaukiee, WI) and 10 mM b-glycerol phosphate (Aldrich).
Histology
Cells cultured on matrices were fixed in 10% formalin (Sigma, St. Louis, MO), dehydrated, and embedded in paraffin using standard procedures. Sections (5 mm thick) were then cut and mounted. Hema- 
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toxylin & Eosin, Masson's trichrome, and von Kossa staining were performed on sections according to standard protocols. 14 
Assays
Cell number on the scaffold was determined using a DNA assay. 13 Matrices were placed in a proteinase K (Sigma) solution for 10 h at 55°C. The total amount of DNA was subsequently determined using the Hoechst 33258 dye and a fluorometer (Hoefer DyNA Quant 200, Pharmacia Biotech, Uppsala, Sweden). The concentration of DNA in solution was converted to a cell number using a conversion factor of 8 pg of DNA per MC3T3-E1 cell. This conversion factor was determined by measuring the amount of DNA from a known cell number. Statistical analysis for all assays was performed using the software package InStat (Graph Pad Software, San Diego, CA).
For measurement of phosphate in the scaffold, matrices were placed in a 15% trichloroacetic acid (Fisher) solution for 24 h. Supernatants were then assayed for phosphate using the method of Heinonen and Lahti. 15 To determine the rate of osteocalcin production by cells cultured on the polymer scaffold, matrices were placed in fresh media and incubated for 24 h at 37°C. Media were collected and analyzed for the quantity of osteocalcin with a radioimmunoassay. Regents for the assay were purchased from Biomedical Technologies Inc. (Stoughton, MA). The measured quantities were normalized with the average number of cells on the scaffold.
RNA isolation and analysis
Total RNA was isolated from tissues developed on the PLG scaffolds by homogenization of the scaffold with a polytron (Brinkman Instruments Inc., Westbury, NY). RNA was extracted as described by Chom- 
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czynski and Sacchi. 16 In brief, the method involves initial purification of total nucleic acid by extraction with phenol, chloroform, and isoamyl alcohol followed by selective precipitation of RNA with sodium acetate at pH 6.0. Aliquots of total RNA were fractionated on 0.8% agarose-formaldehyde gels and blotted onto nitrocellulose paper with 20-fold standard saline citrate buffer (SSC) as described by Thomas. 17 cDNA probes used for hybridization were obtained from the following sources: mouse osteocalcin from Dr. John Wozney (Genetics Institute, Boston, MA), 18 mouse bone sialoprotein 19 from Dr. Marian Young (National Institute of Dental and Craniofacial Research, Bethesda, MD), and human collagen a1(I). 20 All cDNA inserts were excised from plasmid DNA with the appropriate restriction enzymes and purified by agarose gel electrophoresis before labeling with [a-32 P]dCTP (deoxycytosine triphosphate) using a random primer kit (Boehringer-Mannheim, Indianapolis, IN). All prehybridizations and hybridizations were performed in 50% formamide; five-fold SSC, five-fold Denhardt's solution; 50 mM phosphate buffer, pH 6.5; 1% sodium dodecyl sulfate (SDS); and 250 mg/mL of herring sperm DNA at 42°C using an Autoblot hybridization oven (Bellco Glass). Hybridization buffer contained 1 3 10 6 dpm denatured probe per milliliter. bridization, blots were washed twice at 42°C and once at 65°C in two-fold SSC and 0.1% SDS and then twice at 65°C in 0.1-fold SSC and 0.1% SDS (30 min per wash). Blots were detected and quantitatively scanned using an InstantImager (Model A2024, Packard Instrument Co, Downers Grove, IL). All values were normalized for RNA loading by probing blots with cDNA to 18S rRNA. 21 
Electron microscopy
Matrices containing cells were fixed in 1% glutaraldehyde (Sigma) for 30 min and subsequently in 0.1% formaldehyde for 1 day. Samples were then dehydrated, mounted, sputter-coated with gold (Desk II, Denton Vacuum, Cherry Hill, NJ), and imaged with a scanning electron microscope (ISI-DS 130, Topcon).
Mechanical testing
Compression testing was performed on an MTS Bionix 100 (Sintech, Research Triangle Park, NC). A constant strain rate of 1 mm/min was used, and moduli were determined from the stress-strain curves for strains ranging from 0 to 5%.
RESULTS
Osteoblasts were first seeded onto porous PLG matrices to confirm that MC3T3 cells would adhere to these materials. Highly porous PLG matrices (95% porosity; Fig. 1A ) were fabricated by a gas foaming/particulate leaching process, 9 and seeded with MC3T3 cells using a static seeding method. 13 Cells adhered, spread, and formed a monolayer on the surfaces of the polymer (Fig. 1B) . The initial cell density with this seeding method was 2.3 3 10 7 cells/mL of scaffold, and the efficiency of cell adhesion to matrices was 46%.
The osteogenic cells subsequently proliferated on the scaffold to form a three-dimensional tissue in a manner consistent with the proliferation stage of bone formation typically described for preosteoblasts in two-dimensional culture and in vivo. 11 Examination of histological sections stained with hematoxylin and eosin ( Fig. 2A,D ,G) qualitatively confirmed cell proliferation during the early stage of tissue development. A loosely organized confluent cell layer, approximately 2-3 cells thick, was observed near the surface of the polymer (Fig. 2A) . The cell density remained high in the 100 mm below this confluent surface cell layer, but deeper into the tissue the cell density was decreased. After 4 weeks of culture, the surface confluent cell layer had increased to a thickness of approximately 4-5 cells (Fig. 2D) , and the cell density remained high within the 150 mm immediately below the surface. The cellular organization of the engineered tissue had similarities to that of native bone. Cells at the surface had organized into a single layer ( ( Fig. 3A) , consistent with the proliferative phase of osteoblast differentiation. A subsequent decrease in cell density was observed, most likely due to cell necrosis in the scaffold interior resulting from limited nutrient availability.
Cells cultured on the polymer scaffold continuously deposit extracellular matrix (e.g., collagen), a prerequisite for the mineralization phase, throughout the time in culture. Histological sections stained with Masson's trichrome qualitatively demonstrate the increase in the quantity of collagen deposited with time (Fig. 2B,E,H) . Collagen is initially deposited within 100 mm of the surface, with more collagen being deposited in the region between 30 and 100 mm below the surface (Fig. 2B) . Collagen deposition increases through 4 weeks in culture and appears uniformly distributed in the region between 30 and 150 mm of the
FIG. 6.
Osteoblast marker gene expression. Total RNA was extracted from cells cultured on PLG scaffolds for the indicated times. Northern blot was used to examine expression of two osteoblast-specific markers (bone sialoprotein, BSP, and osteocalcin, OCN) at 1, 2, 4, and 8 weeks of culture. The 8-week sample was run on a separate gel; however, hybridization was performed at the same time for all samples. Expression levels were quantified at each time point and normalized to ribosomal RNA for BSP (r ) (A) and OCN (n ) (B). In addition, the production rates for osteocalcin (u ) (C) were determined by assaying the media surrounding the tissues developing on PLG scaffolds. (Fig. 2E) . Ultimately, the deposited collagen is observed at high density, and was continuously distributed from the surface to a depth of 200 mm (Fig. 2H) . Messenger RNA levels for type I collagen (Fig.  4A ) were quantified and normalized to ribosomal RNA levels for all times in culture. Maximal collagen mRNA levels were observed at the 2-week time point; however, the mRNA levels never decreased below 50% of the maximum level. The presence of collagen mRNA at all times is consistent with the observed increase in collagen deposition throughout the time in culture.
Mineralization of the deposited extracellular matrix, the final phase of osteoblast differentiation, was observed after 4 weeks in culture. During this time, cells also expressed genes that signify formation of the osteoblast phenotype. Visualization of von Kossa-stained histologic sections from 4-week cultures revealed nodules of mineral occurring sporadically within 150 mm of the scaffold surface (Fig. 2F) . Ultimately, mineral was distributed uniformly from the scaffold surface to a depth of 200 mm (Fig. 2I) . Mineral deposition was not observed in control samples cultured in the absence of ascorbic acid and b-glycerol phosphate (data not shown). Total scaffold-associated phosphate, one component of the mineral in bone, was quantified as a measure of mineral deposition in the engineered tissues. Phosphate was not detected at the earliest time point. However, the mass of phosphates increased during the remainder of the experiment, consistent with histological observations (Fig. 5) . Formation of the osteoblast phenotype was confirmed by verifying the expression of two osteoblast specific genes, bone sialoprotein (BSP) and osteocalcin (OCN), proteins with postulated roles in matrix mineralization. Messenger RNA levels for BSP (Fig. 6A) and OCN (Fig. 6B ) during the first 4 weeks in culture were low (,20% of maximum). A significant increase in expression of BSP and OCN was observed at 8 weeks in culture, which corresponds with the increase in mineralization observed in histological sections. Additionally, the OCN secretion rate was found to increase with time in culture consistent with the observed increase in its mRNA level (Fig. 6C) .
Culture of osteogenic cells on porous PLG matrices led to the formation of a mechanically stable threedimensional engineered tissue. The compressional modulus of the engineered tissue was determined as one measure of the mechanical properties of the tissue. Prior to matrix mineralization, the developing tissue exhibited mechanical properties similar to that of the original polymer scaffold (Fig. 7) . However, a doubling of the compressive modulus was observed for the engineered tissue at the last time point, which corresponds with the timing for matrix mineralization. A significant increase in the mechanical properties was not seen for control scaffolds not seeded with cells (data not shown). Importantly, the scaffold had sufficient me- chanical properties to guide tissue formation while maintaining the original shape and size of the polymer scaffold (Fig. 8) .
DISCUSSION
The objective of this study was to determine if porous PLG matrices fabricated with a gas-foaming technique provide the appropriate environment for mineralized tissue formation from osteogenic cells. MC3T3-E1 cells seeded onto the polymer scaffold attached and proliferated to form a three-dimensional tissue. The cells deposited an extracellular matrix of collagen and subsequently mineralized this deposited collagen. Matrix mineralization coincided with increased expression of bone sialoprotein and osteocalcin, thus confirming development of the osteoblast phenotype. Ultimately, cells form a mechanically stable three-dimensional mineralized tissue that maintains the size and shape of the original polymer scaffold.
MC3T3-E1 cells, a murine calvaria derived clonal cell line at the osteoprogenitor stage, 22 were used to examine development of a mineralized tissue on these three-dimensional scaffolds. Both primary osteoblasts 23 or stromal osteoblastic cells 24, 25 have been used previously to examine the ability of similar scaffolds to form mineralized tissues in vitro and in vivo. The use of a pre-osteoblast cell line in these studies provides a mechanism to obtain a homogeneous population of osteoprogenitor cells in large quantities. Although these transformed cells are inappropriate for in vivo therapeutic applications, MC3T3-E1 cells enable studies on the differentiation of osteoprogenitor cells, leading to the formation of a mineralized tissue. These cells retain several properties of primary osteoblast cultures including the ability to form a mineralized collagenous extracellular matrix and express osteoblast-related gene products in a defined temporal sequence. 12, 26, 27 The scaffolds used in this study provide an environment that supports mineralized tissue formation and may ultimately be used to repair bone defects either by cell transplantation or by guiding bone regeneration. Previous experiments with porous scaffolds of PGA and PLG fabricated with solvent casting or extrusion processes have demonstrated the ability of these matrices to support the formation of a mineralized tissue. 23, 28 A variety of scaffolding materials, such as collagen, hyaluronic acid, and hydroxyapatite, have been examined for their ability to support bone formation in vivo. [29] [30] [31] [32] One desirable attribute of the PLG polymer scaffold is that the degradation rate can be controlled through the ratio of lactide to glycolide in SHEA ET AL. the polymer. Additionally, scaffolds formed by the gas foaming process may be advantageous because of the ability to deliver bioactive factors (e.g., growth factors, plasmid DNA) 33, 34 for extended times. The gas foaming process avoids the use of organic solvents or high temperatures, which can diminish the activity of many bioactive factors. Delivery of tissue-inductive factors (e.g., BMPs) from these matrices may facilitate tissue regeneration by stimulating the progenitor cells to enhance one or more of the steps (e.g., cell migration, proliferation, or differentiation) in the tissue regeneration process. Scaffolds seeded with cells could be implanted immediately or be cultured in vitro for a period of time before implantation. Alternatively, a scaffold alone could be implanted that would create and maintain a space in vivo while allowing the progenitor cells to migrate into the scaffold through the pores and ultimately regenerate the tissue. Importantly, for this guided tissue regeneration approach, the scaffold must have sufficient mechanical properties to retain its original dimensions following bone formation, which will be important for regenerating specific size defects.
Culture of osteo-progenitor cells on the polymer scaffolds also serves as an in vitro model system to examine the developmental pattern of osteoblasts within this engineered tissue. The accepted model of osteoblast differentiation 11 describes a three-step process (proliferation, matrix maturation, and matrix mineralization) in which specific patterns of gene expression correlate with different steps. For the engineered tissue, the proliferative phase occurs during the first 4 weeks in culture and is characterized by an increase in cell density on the polymer scaffold. These cells deposit extracellular matrix protein (e.g., collagen) onto the polymer scaffold throughout the time in culture. Messenger RNA levels for type I collagen remain high (.50% of maximal expression) for all times, which is consistent with prior observations of MC3T3-E1 cells in two-dimensional culture. 12 Mineralization begins to occur within the scaffold around 4 weeks in culture as observed by the sporadic distribution of mineral in the histological sections at this time. A significant increase in mineral deposition was observed during the remainder of the experiment, which corresponds to a significant increase in the mRNA levels for bone sialoprotein and osteocalcin. Bone sialoprotein and osteocalcin are proteins with a postulated role in matrix mineralization, and their up-regulated expression with mineralization is consistent with the accepted model of osteoblast differentiation. The development of the engineered tissue at both the tissue level (e.g., cell density, matrix content) and the cellular level (e.g., gene expression) is consistent with the model of development established for two dimensional culture systems.
The architecture of the engineered mineralized tissue exhibits a cellular organization similar to that of bone in vivo. Following the initial proliferative phase of osteoblast differentiation, the tissue develops such that a single layer of cells is observed on the surface of the scaffold. Below this surface layer, osteocytelike cells are entrapped within a mineralized extracellular matrix. However, the mechanical properties of the engineered tissue are significantly less than that of native bone, which could limit the immediate applications engineered tissue for bone replacement. For example, the compressive modulus of our engineered tissue is approximately 450 kPA whereas the compressive moduli of compact bone and trabecular bone is approximately 10 GPa and 50 Mpa. 1 Mechanical stimulation of the developing tissue may enhance the mechanical properties of the tissue 35 ; however, the significantly decreased mechanical properties of these tissues are due primarily to the relatively thin layer of tissue that forms (< 200 mm). The onset of mineralization does coincide with an increase in mechanical properties; however, the inability to mineralize the entire scaffold limits the mechanical properties of the polymer/tissue composite. The thin shell of bone formed on the scaffold in this situation is most likely due to mass transport limitations inherent to this in vitro culture system. Cells within the engineered tissue in this system receive nutrients only by diffusion from the surrounding media into the tissue. A high cell density on the exterior of the scaffold may deplete the nutrient supply before the nutrients can diffuse to the scaffold interior. Cells on the interior of the polymer scaffold ultimately become necrotic because of inaccessibility to the nutrients. This limitation can ultimately be overcome in vivo by developing strategies to induce blood vessel ingrowth into the polymer scaffold from the surrounding tissue, allowing for large tissue masses to be engineered. 33, 36 This study, to our knowledge, is the first to demonstrate that the development of a three-dimensional engineered bone tissue from progenitor cells follows the pattern of differentiation typically observed in vivo and in two-dimensional culture systems. The PLG scaffold fabricated by the gas foaming process serves as a suitable substrate for the formation of a three-dimensional mineralized tissue and these scaffolds, possibly in combination with a sustained delivery of tissue-inductive factors, may find utility in enhancing bone regeneration in vivo.
